Haleos Labs' board approved Q2/H1 FY26 consolidated financial results. Half-year revenue reached ₹163.87 Cr and Net Profit ₹10.81 Cr, with EPS at ₹33.93. The company confirmed its name change from SMS Lifesciences India.
Haleos Labs Limited (formerly SMS Lifesciences) has declared a ₹1.50 per share (15%) dividend for FY24-25. Payment is temporarily withheld for shareholders needing to update KYC or correct bank details. Update your information to receive the dividend.
Haleos Labs updated on its physical share transfer re-lodgment window. The company confirmed no requests were received, processed, approved, or rejected under this active opportunity for shareholders.